TROV

TrovaGene, Inc. News Headlines

$3.44
*  
0.09
2.69%
Get TROV Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading TROV now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

TrovaGene To Present At Jefferies Healthcare Conference; Webcast At 4:30 PM ET
6/2/2014 3:00:00 PM - RTT News

TrovaGene (TROV) is Oversold: Can It Recover? - Tale of the Tape
5/20/2014 10:23:58 AM - Zacks.com

Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape
5/16/2014 8:51:00 AM - Zacks.com

bluebird bio (BLUE) Jumps: Stock Adds 27.3% in Session - Tale of the Tape
5/15/2014 9:39:00 AM - Zacks.com

Celldex Therapeutics (CLDX) Soars: Stock Adds 26.9% in Session - Tale of the Tape
5/15/2014 8:51:00 AM - Zacks.com

Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
5/13/2014 8:44:00 AM - Zacks.com

Endocyte, Inc. (ECYT) in Focus: Stock Rises 5.6% - Tale of the Tape
5/6/2014 8:44:01 AM - Zacks.com

Amicus Therapeutics (FOLD) Jumps: Stock Up 20.7% - Tale of the Tape
4/30/2014 9:39:01 AM - Zacks.com

GTX Inc. (GTXI) Jumps: Stock Up 14.4% - Tale of the Tape
4/30/2014 8:51:01 AM - Zacks.com

Revance Therapeutics (RVNC) Soars: Stock Up 25.8% - Tale of the Tape
4/23/2014 9:39:01 AM - Zacks.com

Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape
4/22/2014 9:39:01 AM - Zacks.com

TrovaGene (TROV) Enters Oversold Territory - Tale of the Tape
4/16/2014 11:47:01 AM - Zacks.com

Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO
1/21/2014 7:04:00 AM - Seeking Alpha

Trovagene: Strong Biotech 'January Effect' Candidate For 2014
12/30/2013 4:21:00 PM - Seeking Alpha

Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics
12/25/2013 3:43:00 AM - Seeking Alpha

Can Trovagene Be The Belle Of The Ball?
8/30/2013 9:06:00 AM - Seeking Alpha

An Incredibly Asymmetric Risk/Reward Ratio For Sanuwave Foreshadows Huge Upside
8/13/2013 11:13:00 AM - Seeking Alpha

Does Exact Sciences' $1B Valuation Foreshadow A Bright Future For TrovaGene?
8/3/2013 12:02:00 AM - Seeking Alpha

DNA Giant Illumina's Newest Partnership
7/19/2013 11:51:00 AM - Seeking Alpha

Has Illumina Set Its Sights On TrovaGene As Its Next Acquisition?
6/28/2013 4:27:00 PM - Seeking Alpha

Organovo: Get Rich Or Die Tryin'
5/15/2013 9:13:00 AM - Seeking Alpha

The 4 Healthcare Companies Investors Should Be Watching
5/14/2013 8:01:00 AM - Seeking Alpha

Weekly Stock Watch - Week Of May 13, 2013
5/11/2013 11:06:00 PM - Seeking Alpha

Detecting Investment Potential In Medical Diagnostics Companies
5/7/2013 3:27:00 PM - Seeking Alpha

Why Royalty And Milestone Partnership Dynamics Imply Trovagene Could Triple
5/3/2013 2:44:00 PM - Seeking Alpha